Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2021 | Trimodality therapy versus radical cystectomy for MIBC

Giulio Francolini, MD, University of Florence, Florence, Italy, outlines the results of a pooled analysis investigating the use of trimodality therapy versus radical cystectomy in the treatment of patients with non-metastatic muscle-invasive bladder cancer (MIBC) who do not have comorbidities and are suitable for surgery. The study found that trimodality treatment could offer an alternative treatment to radical cystectomy in non-metastatic MIBC, and results were used to generate Grades of Recommendation, Assessment, Development and Evaluation (GRADE). This interview took place during the 2021 Genitourinary Cancers Symposium.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.